Hepion Pharmaceuticals
Why Robinhood?
You can watch HEPA and buy or sell other stocks, ETFs, and their options commission-free!About HEPA
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate rencofilstat, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease.
HEPA Key Statistics
Stock Snapshot
As of today, Hepion Pharmaceuticals(HEPA) shares are valued at $0.83. The company's market cap stands at 63.19M, with a P/E ratio of -0.90.
Hepion Pharmaceuticals(HEPA) stock opened on 2026-05-01 at —. The price climbed to — and dipped to —.
Hepion Pharmaceuticals(HEPA) shares are trading with a volume of 0, against a daily average of 325.66K.
In the last year, Hepion Pharmaceuticals(HEPA) shares hit a 52-week high of $1.19 and a 52-week low of $0.26.
In the last year, Hepion Pharmaceuticals(HEPA) shares hit a 52-week high of $1.19 and a 52-week low of $0.26.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.